BeOne Medicines AG (BVMF:B1ME34)
Brazil · Delayed Price · Currency is BRL 66.50
0.00 (0.00%)
Last updated: Nov 11, 2025, 10:00 AM GMT-3
BeOne Medicines AG Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 33 | -644.79 | -881.71 | -2,004 | -1,458 | -1,625 | Upgrade |
Depreciation & Amortization | 167.03 | 167.03 | 83.94 | 63.05 | 45.49 | 31.79 | Upgrade |
Other Amortization | 4.73 | 4.73 | 3.74 | 3.23 | 0.97 | - | Upgrade |
Asset Writedown & Restructuring Costs | -13.23 | -13.23 | -8.49 | -27.74 | -28.99 | -4.49 | Upgrade |
Loss (Gain) From Sale of Investments | 24.02 | 24.02 | 16.22 | 22 | -7.63 | -11.83 | Upgrade |
Stock-Based Compensation | 441.62 | 441.62 | 367.62 | 303.16 | 240.71 | 183.48 | Upgrade |
Other Operating Activities | 219.44 | 37.15 | -368.23 | 11.11 | 26.89 | -8.03 | Upgrade |
Change in Accounts Receivable | -329.44 | -329.44 | -188.31 | 304.11 | -423.02 | 10.36 | Upgrade |
Change in Inventory | -91.5 | -91.5 | -140.95 | -56.69 | -153.33 | -58.91 | Upgrade |
Change in Accounts Payable | 121.5 | 121.5 | 21.48 | -4.35 | 20.01 | 95.84 | Upgrade |
Change in Unearned Revenue | 0.63 | 0.63 | -255.59 | -151.82 | 407.7 | - | Upgrade |
Change in Other Net Operating Assets | 141.64 | 141.64 | 192.82 | 41.14 | 30.3 | 103.29 | Upgrade |
Operating Cash Flow | 719.44 | -140.63 | -1,157 | -1,497 | -1,299 | -1,283 | Upgrade |
Capital Expenditures | -229.53 | -492.66 | -561.9 | -325.43 | -262.94 | -117.51 | Upgrade |
Sale (Purchase) of Intangibles | -36.47 | -36.47 | -34.37 | -143.67 | -51.91 | -109.5 | Upgrade |
Investment in Securities | -1,288 | -16.35 | 658.34 | 1,548 | 955.51 | -2,939 | Upgrade |
Other Investing Activities | -8.74 | -2.86 | -2.08 | -1.49 | - | -2.03 | Upgrade |
Investing Cash Flow | -1,563 | -548.35 | 60 | 1,077 | 640.66 | -3,168 | Upgrade |
Short-Term Debt Issued | - | 868.27 | 661.53 | 313.77 | 406.45 | 323.7 | Upgrade |
Long-Term Debt Issued | - | 9.05 | 22.5 | 37.37 | 16.84 | 110.21 | Upgrade |
Total Debt Issued | 763.41 | 877.32 | 684.03 | 351.15 | 423.29 | 433.91 | Upgrade |
Short-Term Debt Repaid | - | -704.22 | -309.58 | -417.08 | -321.75 | -12.25 | Upgrade |
Long-Term Debt Repaid | - | -28.03 | -13.69 | - | - | -132.06 | Upgrade |
Total Debt Repaid | -855.17 | -732.25 | -323.27 | -417.08 | -321.75 | -144.31 | Upgrade |
Net Debt Issued (Repaid) | -91.76 | 145.08 | 360.77 | -65.94 | 101.53 | 289.6 | Upgrade |
Issuance of Common Stock | 186.87 | 45.37 | 55.71 | 46.96 | 3,535 | 4,325 | Upgrade |
Other Financing Activities | 853.75 | 3 | - | - | - | 588.11 | Upgrade |
Financing Cash Flow | 924.94 | 193.45 | 416.48 | -18.97 | 3,637 | 5,203 | Upgrade |
Foreign Exchange Rate Adjustments | -36.53 | -51.71 | -8.08 | -69.38 | 14.04 | 18.23 | Upgrade |
Net Cash Flow | 45.31 | -547.24 | -689.05 | -507.85 | 2,993 | 769.23 | Upgrade |
Free Cash Flow | 489.91 | -633.29 | -1,719 | -1,822 | -1,562 | -1,401 | Upgrade |
Free Cash Flow Margin | 9.80% | -16.62% | -69.93% | -128.68% | -132.76% | -453.57% | Upgrade |
Free Cash Flow Per Share | 4.37 | -6.01 | -16.47 | -17.67 | -16.83 | -16.78 | Upgrade |
Cash Interest Paid | 51.18 | 51.18 | 19.75 | 25.17 | 29.97 | 44.13 | Upgrade |
Cash Income Tax Paid | 157.94 | 69.43 | 56 | 29.5 | 15.7 | 10.6 | Upgrade |
Levered Free Cash Flow | 296.22 | -367 | -1,274 | -943.69 | -1,204 | -752.29 | Upgrade |
Unlevered Free Cash Flow | 305.43 | -357.79 | -1,271 | -931.75 | -1,186 | -741.06 | Upgrade |
Change in Working Capital | -157.17 | -157.17 | -370.54 | 132.39 | -118.35 | 150.58 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.